Seroba Life Sciences logo

Seroba Life Sciences

Crunchbase
Pitchbook
Crunchbase

Deals on record

4

Common Fundraising Type

Series B

Coave Therapeutics logo
Coave Therapeutics

Genetic medicines

UI Investissement logo
Turenne Capital logo
Seroba Life Sciences logo
Omnes Capital logo
Novo Holdings logo
Kurma Partners logo
Invus logo
Fund+ logo

Coave Therapeutics develops genetic medicines using their ALIGATER™ platform to enhance treatment for CNS, neuromuscular, and eye diseases.

Series A
$33M
01/09/2025
Article

Deciphex is an AI-powered digital pathology company that enhances diagnostic efficiency and accuracy for pathologists.

Series C
$32.3M
01/07/2025
Article
ShiraTronics logo
ShiraTronics

Medical device

Norwest Venture Partners logo
U.S. Venture Partners logo
Treo Ventures logo
Seroba logo
OSF Ventures logo
Global BioAccess Fund logo
Aperture Venture Partners logo
Amzak Health logo

ShiraTronics develops a neuromodulation device for treating chronic migraine patients.

Series B
$66M
10/09/2024
Article
Shorla Oncology logo
Shorla Oncology

Pharmaceutical

Seroba Life Sciences logo
Kurma Partners logo
Enterprise Ireland logo

Shorla Oncology is a pharmaceutical company that develops oncology drugs for orphan and pediatric cancers, with a focus on addressing drug shortages and improving the preparation and application of oncology medication.

Series B
$35M
10/04/2023
Article